中國交通建設(01800.HK)擬投資巴西巴伊亞州跨海大橋及配套公路項目
格隆匯6月9日丨中國交通建設(01800.HK)公告,中國交通建設股份有限公司第四屆董事會第三十六次會議決議。審議通過《關於投資巴西巴伊亞州薩爾瓦多-伊塔帕利卡跨海大橋及配套公路項目及所涉關聯(連)交易的議案》。
(一)原則同意公司與公司附屬公司中交南美區域公司(簡稱中交南美)以及第三方,共同投資巴西巴伊亞州薩爾瓦多-伊塔帕利卡跨海大橋及配套公路項目。
(二)同意公司接受中交南美的參股股東上海振華重工(集團)股份有限公司(簡稱振華重工)和中交海外房地產有限公司(簡稱中交海外地產),就中交南美的股東提案權和表決權的委託。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.